Abstract: The present invention relates to the Nalmefene hydrochloride dihydrate, methods of manufacturing Nalmefene hydrochloride dihydrate, a pharmaceutical composition comprising Nalmefene hydrochloride dihydrate and a method of treatment comprising administering Nalmefene hydrochloride dihydrate.
Type:
Grant
Filed:
December 4, 2009
Date of Patent:
September 10, 2013
Assignees:
H. Lundbeck A/S, Bioei Therapies Corp
Inventors:
Heidi Lopez de Diego, Carla de Faveri, Florian Anton Martin Huber